History Lessons can serve as important DD PW
BIEL is 21
History Lessons can serve as important DD PW
BIEL is 21 years old (quiz clue) but the Key Events that have brought BIEL to Partnerships with KT Tape and DJO Global happened in the last 7 years.
* Updated design of the ActiPatch 2014, the old style left the electronics exposed to damage, funky on/off mechanism
* FDA Reclassification to Class 2 2015, this was a critical achievement, without Class 2 BIEL would never have seen an FDA OTC Clearance and would still be Prescription Only
* First FDA OTC Clearance, two indications 2017, BIEL proved to the FDA that ActiPatch was Safe and Effective for Over the Counter use, 4 years later BIEL still has the only FDA OTC Cleared PEMF/PSWT Product
* NHS Drug Tariff Listing 2018, while BIEL has not yet been able to directly monetize this event the notoriety of an NHS Listing placed BIEL on the radar of many companies
* RecoveryRx FDA Post-op Pain Clearance 2019, this Clearance made RecoverRx available to the millions of surgery patients, becoming more important each year as Opioid Pain Killers get more restricted
* Change of Business Plan from Retail Sales to OEM Supplier 2020, realizing that BIEL did not have the resources to market ActiPatch to 300 million Americans new management focused on OEM for US marketing, Partnering with large companies who have name recognition and resources
* FDA OTC Full Body Musculoskeletal Pain Clearance 2020, the Jewel in BIEL's Crown, the Clearance that made ActiPatch a hot commodity to large companies like KT Tape, DJO Global and SAI Brands (quiz clue)
Things never seem to happen fast enough in the business world and there are always unexpected setbacks. BIEL had an epic setback with the Covid Pandemic but they weathered the storm and are in a excellent position to monetize all of their achievements.
2
BioElectronics Corporation (BIEL) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Throw away those dusty, old reputation surveys—Davos Healthcare just turned the spotlight onto cold, hard data with its new global hospital evaluation platform. Why Davos Healthcare’s Initiative Matters At the C3 US NYC Davos of Healthcare™ Summit, an event that’s rooted itself alongside the United Nations General Assembly, Davos Healthcare unveiled a...
Continue Reading
AI-Driven Insights: Revolutionizing Private Equity Strategies Now this is some spicy news from Huntington Beach! Collective just pulled back the curtain on Compass, their AI-fueled platform that's set to shake up how financial advisors tackle private company equity. If you're an advisor who's sick of staring at nebulous balance sheets filled with unquantifiable private...
Continue Reading
Revolutionizing Financial Operations: FutureVault's AI Approach In the dizzying whirlwind of financial services, the launch of FutureVault AI Agents is a game-changer for document management. This isn't some half-baked tool; it's a full-fledged overhaul of how compliance and operations should tick in the modern age. We've all seen it—a paper trail tangled across systems...
Continue Reading
Lumi: Changing the Car Buying Game Picture this: You're browsing for a new car, head filled with specifics like towing capacity, price points, and trim options. Usually, such queries would send you bouncing around the web, but Lectrium's Lumi promises to keep the questioning—and decision-making—right on the dealership's page. In a move set to shake up the game,...
Continue Reading
Glo Taps Top Wellness Expert for Women's Health Initiative In an industry brimming with wellness voices, it's rare to find one that marries scholarly acumen with authentic, personal teaching. Yet, this is precisely what Dr. Desi Bartlett brings to the table as she partners with Glo to offer new fitness programming specifically targeting women facing perimenopause and...
Continue Reading
When Maesa pulls back the curtain, they don't just crack it open—they fling it aside with flair. That's precisely what they're doing with their latest venture, Anecdotes by Artists, a fragrance brand that's taking its first bow exclusively at Sephora. It's not your average perfume launch; it's about the stories behind the scents and the artists who craft them. Unveiling...
Continue Reading
In the sprawling world of antibody discovery, where every scrap of data can make or break the next big breakthrough, FairJourney Bio (FJBio) is pulling out all the stops. They've teamed up with Sapio Sciences to ditch the paperwork nightmares and usher in a new era of AI-driven efficiency. With operations stretching from Porto to Cambridge to sunny San Diego, they’re...
Continue Reading
Decades of an Unchecked Revolving Door The Environmental Protection Agency (EPA) and chemical manufacturers—a dance that’s been going on for what seems like forever. But not in the way you might hope. We're talking about a revolving door where execs and lobbyists waltz into regulatory chairs while regulators slide into cushy industry gigs. Wisner Baum LLP, a stickler...
Continue Reading
America's New Obsession: Convenience at a Cost Diving into the relentless hustle, Americans are shelling out big bucks to dodge life's mundane chores. A fresh survey dished out by FinanceBuzz, hitching a ride with Bank of America, gives us a peek into how hooked everyone is on convenience services like food and grocery deliveries. It’s clear people are ready to fork...
Continue Reading
Dallas' Hot Market and Machine's Bold Move Well, well, looks like Machine Investment Group's been busy flexing its real estate muscles, bagging a 490-unit gem in North Dallas—your typical, no-frills off-market grab. We’re talking 75 West, nestled in a juicy infill spot, and it’s catching eyes like gold dust in a pan. You don't need me to tell you North Dallas ain't...
Continue Reading
Top 5 Most Recently Viewed Articles
BMO Capital Stays Optimistic About CrowdStrike Stock BMO Capital has reaffirmed its positive outlook for CrowdStrike Holdings (NASDAQ: CRWD) by maintaining an Outperform rating and setting a price target of $315.00 for the company’s stock. This encouraging review follows the recent Fal.Con 2024 user group and analyst event conducted by CrowdStrike, where the firm's...
Continue Reading
XBiotech Investigation: Understanding the Current Situation XBiotech Inc. is currently under scrutiny as Pomerantz LLP, a leading law firm, investigates claims on behalf of investors. This situation arises from potential securities fraud and other unlawful business practices involving certain officers and directors of the company. Investors are encouraged to remain...
Continue Reading
Understanding FedEx's Options Activity In the world of finance, observing options activity can offer unique insights into stock performance and market sentiments. FedEx Corp (FDX) is no exception to the attention of savvy traders and institutional players. Recently, an analysis of FedEx's options transactions unveiled notable patterns that merit discussion. Current Market...
Continue Reading
Northern Trust’s Business Owner Benchmark Report Northern Trust has recently published its third Business Owner Benchmark report, showcasing the ambitious plans that business owners have for the future. The insights are drawn from a survey conducted among Northern Trust’s business owner clients, revealing a willingness to embrace significant changes despite varied...
Continue Reading
Post Holdings Unveils $600 Million Senior Notes Offering Post Holdings, Inc. (NYSE: POST), a prominent player in the consumer packaged goods sector, has recently announced a significant financial step by issuing $600 million in senior notes. This issuance, as reported in an 8-K filing with the Securities and Exchange Commission, carries an interest rate of 6.250%, with a...
Continue Reading